SER Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Serina Therapeutics Inc (SER) is not a strong buy at this time for a beginner investor with a long-term strategy. The lack of significant positive catalysts, insider selling, and absence of financial and valuation data make it prudent to hold off on investing until more favorable conditions emerge.
The MACD is positive and expanding, indicating a bullish momentum. RSI is in the neutral zone at 72.686, not signaling overbought or oversold conditions. Moving averages are converging, suggesting no clear trend. The price is currently above the pivot level (1.929) but within resistance levels (R1: 2.109, R2: 2.219).
The stock showed a 6.06% increase in the regular market and a 1.43% increase post-market. MACD indicates bullish momentum.
Insider selling has increased by 489.78% over the last month, which is a bearish signal. No recent news or significant hedge fund activity. Congress trading data is unavailable. Financial and valuation data are missing.
No financial data available for analysis.
No analyst rating or price target changes available.
